Clinical Trials
323
Trial Phases
6 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (210 trials with phase data)• Click on a phase to view related trials
Artificial Intelligence-powered Low-Dose Computed Tomography for Screening of Pancreatic Cancer
- Conditions
- Pancreatic CancerIntraductal Papillary Mucinous NeoplasmHigh-grade Pancreatic Intraepithelial NeoplasiaPDAC - Pancreatic Ductal AdenocarcinomaMucinous Cystic Neoplasm
- First Posted Date
- 2025-08-12
- Last Posted Date
- 2025-08-12
- Lead Sponsor
- Changhai Hospital
- Target Recruit Count
- 400000
- Registration Number
- NCT07117045
- Locations
- 🇨🇳
Meinian Onehealth Healthcare Holdings Co., Ltd, Shanghai, Shanghai, China
🇨🇳Ruici Medical Examination Institution, Shanghai, Shanghai, China
🇨🇳Changhai Hospital, Shanghai, Shanghai, China
Perioperative Blood Transfusion and Increased One-year Mortality
- Conditions
- Mortality, Perioperative Blood Transfusion, Propensity Score, Retrospective Study, Surgery
- First Posted Date
- 2025-07-30
- Last Posted Date
- 2025-07-30
- Lead Sponsor
- Changhai Hospital
- Target Recruit Count
- 97443
- Registration Number
- NCT07094295
Comparison of the Sensitivity of pCLE and Pathological Biopsy Before ESD
- Conditions
- Gastric Cancer (Diagnosis)Gastric High-grade Intraepithelial NeoplasiaGastric Low-grade Intraepithelial NeoplasiaGastritis
- First Posted Date
- 2025-07-28
- Last Posted Date
- 2025-07-28
- Lead Sponsor
- Changhai Hospital
- Target Recruit Count
- 169
- Registration Number
- NCT07088744
- Locations
- 🇨🇳
Guangxi Zhuang Autonomous Region People's Hospital, Nanning, Guangxi, China
🇨🇳Northern Theater Command Hospital, Shenyang, Liaoning, China
🇨🇳West China Hospital of Sichuan University, Chengdu, Sichuan, China
Low-Dose vs Standard-Dose Indomethacin for Preventing Post-ERCP Pancreatitis
- Conditions
- Post-ERCP Pancreatitis
- Interventions
- Drug: low dose indomethacin
- First Posted Date
- 2025-07-28
- Last Posted Date
- 2025-07-28
- Lead Sponsor
- Changhai Hospital
- Target Recruit Count
- 1366
- Registration Number
- NCT07088757
- Locations
- 🇨🇳
Changhai Hospital, Shanghai, China
🇨🇳Ruijin Hospital, Shanghai, China
🇨🇳Shanghai General Hospital, Shanghai, China
Endotherapy and/or Extracorporeal Shockwave Lithotripsy for Painless Chronic Pancreatitis
- Conditions
- Painless Chronic Pancreatitis
- Interventions
- Behavioral: Lifestyle modificationsDrug: Pancreatic enzyme (Pancreatin Enteric-coated Capsules or Oryz-Aspergillus Enzyme and Pancreatin Table), antidiabetic medicine(Acarbose , Metformin, Glimepirde Tablets, Insulin)Procedure: Endoscopic Retrograde Cholangiopancreatography (ERCP) and/or Extracorporeal Shockwave Lithotripsy (ESWL)
- First Posted Date
- 2025-07-20
- Last Posted Date
- 2025-08-06
- Lead Sponsor
- Changhai Hospital
- Target Recruit Count
- 126
- Registration Number
- NCT07074379
- Locations
- 🇨🇳
Changhai Hospital, Shanghai, Shanghai, China
- Prev
- 1
- 2
- 3
- 4
- 5
- 64
- Next
News
PROTECT-MT Trial Suggests Worse Outcomes with Balloon Guide Catheters in Stroke Thrombectomy
The PROTECT-MT trial, a randomized controlled study, indicated that stroke thrombectomy using balloon guide catheters (BGCs) may lead to inferior functional outcomes compared to conventional guide catheters.